MONTECET
Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Levocetirizine HCL, is an orally active H1-receptor antagonist.
Q-RETIC
Furosemide is a loop diuretic used to treat fluid retention (edema) in people with congestive heart failure, liver disease, or a kidney disorder such as nephrotic syndrome. Furosemide is also used to treat high blood pressure (hypertension).
Label
Formulation and Dosage
Indication
Distribution
Label
10 mg/ml (20 mg/ 2ml)
Solution for Injection (I.M/I.V)
DIURETIC
STORAGE CONDITIONS:
Store at temperatures not exceeding 30°C
Formulation and Dosage
FORMULATION:
Each ml contains:
Furosemide BP ……………………………… 10mg
DOSAGE AND ADMINISTRATION:
Furosemide may be administered intramuscularly or intravenously as the sodium salt. It is recommended that whether by direct intravenous injection or by infusion, the rate of intravenous administration should not exceed 4 mg / minute although some authorities advise that a single dose of up to 50 mg may have given more rapidly.
For edema: 20-50 mg of Furosemide may be administered by intramuscular or slow intravenous injection and if necessary further doses may be given, increasing by 20 mg increments and not given more often than every 2 hours. If doses are greater than 50 mg are required they should be given by slow intravenous infusion.
For pulmonary edema: if an initial slow intravenous injection of 40mg dose does not produce a satisfactory response within 1 hour, the dose may be increased to 80 mg given slowly intravenously.
For Children: 0.5 to 1.5 mg per kg daily up to a maximum of 20mg daily.
High dose therapy: 250 mg diluted to 250 ml in a suitable diluent is infused over 1 hour. If urine output is sufficient within the next hour this dose may be followed by 500 mg added to an appropriate infusion fluid, the total volume which must be governed by the patient’s state of hydration and infused over approximately 2 hours or as prescribed by physician.
Indication
INDICATIONS:
Used in the treatment of edema associated with heart failure including pulmonary edema, and with renal and hepatic disorders and may be effective in patients unresponsive to thiazide diuretics.
Distribution
FDA Registration Number: DRP-8351-03
Manufacturer: FUREN PHARMACEUTICAL GROUP CO.,LTD.
Product Categories
Share this Product:
Other Products
Q-CETYL
Acetylcysteine exerts an intensive mucolytic-fluidifying action on the mucous and mucopurulent secretions by depolymerizing the mucoprotein complexes and the nucleic acids which confer viscosity to the vitreous and purulent component of the sputum and other secretions.
Q-MEP
Omeprazole is used to treat excess stomach acid in conditions such as non cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from the group of medicines called proton pump inhibitors.
SALBUGEN PLUS
The combination of salbutamol with guaifenesin is designed to relieve respiratory obstruction and improve pulmonary ventilation. Respiratory disorders where bronchospasm and excessive secretion of tenacious mucus are complicating factors, e.g. bronchial asthma, chronic bronchitis and emphysema.